1. Home
  2. PHAT vs PDYN Comparison

PHAT vs PDYN Comparison

Compare PHAT & PDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • PDYN
  • Stock Information
  • Founded
  • PHAT 2018
  • PDYN 1983
  • Country
  • PHAT United States
  • PDYN United States
  • Employees
  • PHAT N/A
  • PDYN N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • PDYN Wholesale Distributors
  • Sector
  • PHAT Health Care
  • PDYN Industrials
  • Exchange
  • PHAT Nasdaq
  • PDYN Nasdaq
  • Market Cap
  • PHAT 289.0M
  • PDYN 225.7M
  • IPO Year
  • PHAT 2019
  • PDYN N/A
  • Fundamental
  • Price
  • PHAT $4.25
  • PDYN $7.87
  • Analyst Decision
  • PHAT Strong Buy
  • PDYN
  • Analyst Count
  • PHAT 4
  • PDYN 0
  • Target Price
  • PHAT $16.25
  • PDYN N/A
  • AVG Volume (30 Days)
  • PHAT 2.2M
  • PDYN 1.9M
  • Earning Date
  • PHAT 05-01-2025
  • PDYN 05-07-2025
  • Dividend Yield
  • PHAT N/A
  • PDYN N/A
  • EPS Growth
  • PHAT N/A
  • PDYN N/A
  • EPS
  • PHAT N/A
  • PDYN N/A
  • Revenue
  • PHAT $81,859,000.00
  • PDYN $6,055,000.00
  • Revenue This Year
  • PHAT $195.45
  • PDYN N/A
  • Revenue Next Year
  • PHAT $106.76
  • PDYN $97.52
  • P/E Ratio
  • PHAT N/A
  • PDYN N/A
  • Revenue Growth
  • PHAT 3055.70
  • PDYN N/A
  • 52 Week Low
  • PHAT $2.21
  • PDYN $1.38
  • 52 Week High
  • PHAT $19.71
  • PDYN $14.95
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 54.83
  • PDYN 63.08
  • Support Level
  • PHAT $3.92
  • PDYN $7.27
  • Resistance Level
  • PHAT $4.35
  • PDYN $8.74
  • Average True Range (ATR)
  • PHAT 0.40
  • PDYN 0.82
  • MACD
  • PHAT 0.13
  • PDYN 0.13
  • Stochastic Oscillator
  • PHAT 85.63
  • PDYN 70.71

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

Share on Social Networks: